You are here:
Select the mission or strategic goal number below to track Gavi's progress against its targets for the 2011-2015 strategy:
Gavi Board paper defining both the key performance indicators that will be used to monitor progress against the 2011-15 Gavi strategy and how they are calculated.
Over the course of a decade, the weighted average price of pentavalent vaccine (DTP-hepB-Hib) dropped by 43% from US$ 3.56 per dose in 2003 to US$ 2.04 per dose in 2013, with a lowest-ever price of US$ 1.19 from one supplier in 2013.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here